![(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles](/docs/US/2023-08-15/US11725004B2/abs.jpg.600x600.jpg)
- 专利标题： (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
-
申请号： US17398155申请日： 2021-08-10
-
公开(公告)号： US11725004B2公开(公告)日： 2023-08-15
- 发明人: Doris Riether , Florian Paul Christian Binder , Henri Doods , Stephan Georg Mueller , Janet Rachel Nicholson , Achim Sauer
- 申请人： Centrexion Therapeutics Corporation
- 申请人地址： US MA Boston
- 专利权人： Centrexion Therapeutics Corporation
- 当前专利权人： Centrexion Therapeutics Corporation
- 当前专利权人地址： US MA Boston
- 代理机构： Dechert LLP
- 优先权： EP 168165 2013.05.17
- 主分类号： C07D417/12
- IPC分类号： C07D417/12 ; C07D413/12 ; C07D261/14 ; C07D413/14 ; C07D413/02 ; C07D261/04 ; A61K31/422
![(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles](/abs-image/US/2023/08/15/US11725004B2/abs.jpg.150x150.jpg)
摘要：
This invention relates to novel (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles and their use as CB2 cannabinoid receptor agonists, pharmaceutical compositions containing the same, and their use for the treatment of CB2 receptor mediated disorders or conditions.
公开/授权文献
信息查询
